Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway.

Ruan B, Zhu Z, Yan Z, Yang W, Zhai D, Wang L, Ye Z, Lu H, Xiang A, Liang J, Jiang Y, Xu C, Wang Z, Wei M, Lei X, Cao X, Lu Z

Open source

DOI: 10.1186/s13287-018-0771-y
Published: 2018 Mar 9
Container: Stem cell research & therapy
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13287-018-0771-y,
  title = {Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway.},
  author = {Ruan B and Zhu Z and Yan Z and Yang W and Zhai D and Wang L and Ye Z and Lu H and Xiang A and Liang J and Jiang Y and Xu C and Wang Z and Wei M and Lei X and Cao X and Lu Z},
  year = {2018},
  journal = {Stem cell research \& therapy},
  doi = {10.1186/s13287-018-0771-y},
  url = {https://doi.org/10.1186/s13287-018-0771-y}
}

RIS

TY  - JOUR
TI  - Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway.
AU  - Ruan B
AU  - Zhu Z
AU  - Yan Z
AU  - Yang W
AU  - Zhai D
AU  - Wang L
AU  - Ye Z
AU  - Lu H
AU  - Xiang A
AU  - Liang J
AU  - Jiang Y
AU  - Xu C
AU  - Wang Z
AU  - Wei M
AU  - Lei X
AU  - Cao X
AU  - Lu Z
PY  - 2018
JO  - Stem cell research & therapy
DO  - 10.1186/s13287-018-0771-y
UR  - https://doi.org/10.1186/s13287-018-0771-y
ER  -

APA

B, R., Z, Z., Z, Y., W, Y., D, Z., L, W., Z, Y., H, L., A, X., J, L., Y, J., C, X., Z, W., M, W., X, L., X, C., & Z, L. (2018). Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway.. Stem cell research & therapy. https://doi.org/10.1186/s13287-018-0771-y

Source records

pubmed · retrieved 2026-09-25T21:05:49.287Z